MTAP and neoplasm: Through phenotypic analysis, favorable clinical response to ICTs, elevated expression of immune checkpoints, increased abundance of tumor-infiltrated lymphocyte infiltration, and elevated TMB and PD-L1 expression were observed in the MTAP/CDKN2AMUT cluster.